"The only real security a person can have in this world is a reserve of knowledge, experience and ability."
-- Henry Ford
-- Henry Ford
Dr. Richard A. Davis provides expert toxicology, safety evaluation and risk assessment services in the areas of occupational health and regulatory affairs related to chemicals, pesticides, pharmaceuticals and associated materials. He designs toxicology and other safety studies, monitors their conduct for protocol and GLP compliance, evaluates and interprets results. Examples of the types of work and service he has provided are listed below:
General Toxicology
Literature searches, summary, evaluation and interpretation - ToxPro-files
Toxicology studies - design, monitor, evaluate, report
- All exposure routes
- Acute studies
- Allergic sensitization - dermal and respiratory
- Subchronic studies
- Chronic studies
- Developmental studies
- Reproduction studies
- Genotoxicity / mutagenicity studies
- Neurotoxicology studies
- Environmental / ecotoxicity studies
- Combustion toxicity studies
Product Safety
Carcinogen Classification
Hazard Classification
Label Warning Statements
MSDS Preparation
EU R- and S-Phrases
Canadian Hazardous Product Act
Canadian Consumer Chemicals and Containers Regulations
Federal Hazardous Substances Act
Labeling of Hazardous Art Materials
ASTM D-4236 Certification
Occupational Health
Worker Health & Safety Training
Determination of Occupational Exposure Standards (OEL, PEL, TLV, STEL)
Performance Based Exposure Controls
Inhalation Toxicity Testing
Health Surveillance
Risk Assessment
Benchmark Dose
Determination of ADI, RfD, RfC, MOE
Pesticide Operator Exposure Assessments
Health effect Assessments
Threshold of Concern (TOC)
Regulatory Affairs
Chemicals
- EU premarket notifications
- TSCA 5(e) premanufacture notications
- TSCA 8(e) compliance
- HPV summaries and testing plans
- NSF 61 safety assessment and certification of chemicals imparted to drinking water
- Threshold of Regulation
Pesticides
- FIFRA registrations
- EU 91/414 dossier preparation
- JMAFF / JACIS submissions
Pharmaceuticals
- IND, NDA summaries
- Safety pharmacology studies